103 related articles for article (PubMed ID: 7426025)
1. Showdomycin and its reactive moiety, maleimide. A comparison in selective toxicity and mechanism of action in vitro.
Uehara Y; Fisher JM; Rabinovitz M
Biochem Pharmacol; 1980 Aug; 29(16):2199-204. PubMed ID: 7426025
[No Abstract] [Full Text] [Related]
2. Transport-dependent membrane damage and the irreversible inactivation of nucleoside transport by showdomycin.
Uehara Y; Rabinovitz M
Biochem Pharmacol; 1981 Dec; 30(23):3165-9. PubMed ID: 7317101
[No Abstract] [Full Text] [Related]
3. Some chemical and biological characteristics of showdomycin.
Titani Y; Tsuruta Y
J Antibiot (Tokyo); 1974 Dec; 27(12):956-62. PubMed ID: 4619627
[No Abstract] [Full Text] [Related]
4. Transport studies of showdomycin, nucleosides and sugars in Escherichia coli B and in showdomycin-resistant mutants.
Roy-Burman S; Visser DW
Biochim Biophys Acta; 1972 Sep; 282(1):383-92. PubMed ID: 4560820
[No Abstract] [Full Text] [Related]
5. A showdomycin-resistant mutant of Escherichia coli K-12 with altered nucleoside transport character.
Komatsu Y; Tanaka K
Biochim Biophys Acta; 1972 Nov; 288(2):390-403. PubMed ID: 4563236
[No Abstract] [Full Text] [Related]
6. The role of the maleimide ring system on the structure-activity relationship of showdomycin.
Rosenqvist P; Mäkinen JJ; Palmu K; Jokinen J; Prajapati RK; Korhonen HJ; Virta P; Belogurov GA; Metsä-Ketelä M
Eur J Med Chem; 2022 Jul; 237():114342. PubMed ID: 35439612
[TBL] [Abstract][Full Text] [Related]
7. Showdomycin analogues: synthesis and antitumor evaluation.
Numao N; Hemmi H; Naujokaitis SA; Rabinovitz M; Beisler JA
J Med Chem; 1981 May; 24(5):515-20. PubMed ID: 7241509
[TBL] [Abstract][Full Text] [Related]
8. Substrate specificity, kinetics, and stoichiometry of sodium-dependent adenosine transport in L1210/AM mouse leukemia cells.
Dagnino L; Bennett LL; Paterson AR
J Biol Chem; 1991 Apr; 266(10):6312-7. PubMed ID: 1848853
[TBL] [Abstract][Full Text] [Related]
9. Showdomycin, a nucleotide-site-directed inhibitor of (Na+ + K+)-ATPase.
Tobin T; Akera T
Biochim Biophys Acta; 1975 Apr; 389(1):126-36. PubMed ID: 124587
[TBL] [Abstract][Full Text] [Related]
10. Differential competition with cytotoxic agents: an approach to selectivity in cancer chemotherapy.
Rabinowitz M; Uehara Y; Vistica DT
Science; 1979 Nov; 206(4422):1085-7. PubMed ID: 493993
[TBL] [Abstract][Full Text] [Related]
11. Differential cytotoxicity of cytosine arabinoside toward murine leukemia L1210 cells and murine bone marrow progenitor cells inhibited in nucleoside transport by cimicifugoside.
Hemmi H
Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):565-8. PubMed ID: 6791252
[TBL] [Abstract][Full Text] [Related]
12. Deamination of arabinosyladenine by adenosine deaminase and inhibition by arabinosyl-6-mercaptopurine.
Chao DL; Kimball AP
Cancer Res; 1972 Aug; 32(8):1721-4. PubMed ID: 5044132
[No Abstract] [Full Text] [Related]
13. Beta-D-Ribofluranosyl-1,4-benzoquinone - antibacterial agent with showdomycin-like mode of action.
Doskocil J; Kalvoda L; Krupicka J
Biochem Biophys Res Commun; 1975 Jan; 64(3):932-8. PubMed ID: 1096888
[No Abstract] [Full Text] [Related]
14. [Modification of radiation effect by showdomycin on hair roots of the mouse (author's transl)].
Egawa J; Ishioka K
Nihon Igaku Hoshasen Gakkai Zasshi; 1974 Oct; 34(10):763-8. PubMed ID: 4533784
[No Abstract] [Full Text] [Related]
15. Inhibition of amino acid and sugar transport by showdomycin.
Roy-Burman S; Huang YH; Visser DW
Biochem Biophys Res Commun; 1971 Feb; 42(3):445-53. PubMed ID: 5542893
[No Abstract] [Full Text] [Related]
16. The effects of antibiotics and cancer chemotherapeutic agents on the cellular transport and antitumor activity of methotrexate in L1210 murine leukemia.
Zager RF; Frisby SA; Oliverio VT
Cancer Res; 1973 Jul; 33(7):1670-6. PubMed ID: 4124487
[No Abstract] [Full Text] [Related]
17. Glycolipid formation in Volvox carteri f. nagariensis: effects of tunicamycin and showdomycin.
Müller T; Bause E; Jaenicke L
FEBS Lett; 1981 Jun; 128(2):208-12. PubMed ID: 7262312
[No Abstract] [Full Text] [Related]
18. Reversal of inhibiting action of showdomycin on the proliferation of Escherichia coli by nucleosides and thiol compounds.
Nishimura H; Komatsu Y
J Antibiot (Tokyo); 1968 Apr; 21(4):250-4. PubMed ID: 4876578
[No Abstract] [Full Text] [Related]
19. Heterogeneity of nucleoside transport in mammalian cells. Two types of transport activity in L1210 and other cultured neoplastic cells.
Belt JA
Mol Pharmacol; 1983 Nov; 24(3):479-84. PubMed ID: 6314117
[TBL] [Abstract][Full Text] [Related]
20. The effect of showdomycin on glycolipid formation. Inhibition of glucosyl-phosphoryl-dolichol in aorta and stimulation of glucosylceramide in yeast.
Kang MS; Spencer JP; Elbein AD
J Biol Chem; 1979 Oct; 254(20):10037-43. PubMed ID: 385593
[No Abstract] [Full Text] [Related]
[Next] [New Search]
